Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

ESPRESPR
28 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in ESPERION THERAPEUTICS INC NE

TWO SIGMA INVESTMENTS, LP holds 7.1M shares of ESPR (ESPERION THERAPEUTICS INC NE), worth $22.5M as of 2026-Q2. The position was decreased (-24.6% shares). ESPR represents 0.0% of TWO SIGMA INVESTMENTS, LP's portfolio.

Current Value

$22.5M

Current Shares

7.1M

Total Value Change

+$21.5M

Total Shares Change

+7.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
7.1M
-24.6%
$22.5M0.0%$3.16
0
2026-Q1
Increased
9.5M
+99.5%
$25.9M0.0%$2.91
46
2025-Q4
Increased
4.7M
+111.8%
$17.5M0.0%$3.69
46
2025-Q3
Increased
2.2M
+22.5%
$5.9M0.0%$2.64
33
2025-Q2
Decreased
1.8M
-33.1%
$1.8M0.0%$0.99
0
2025-Q1
Decreased
2.7M
-22.9%
$3.9M0.0%$1.50
0
2024-Q4
Decreased
3.5M
-2.3%
$7.8M0.0%$2.15
0
2024-Q3
Decreased
3.6M
-11.0%
$6M0.0%$1.68
0
2024-Q2
Increased
4.1M
+2.5%
$9M0.0%$2.22
28
2024-Q1
Increased
4M
+70.3%
$10.7M0.0%$2.68
41
2023-Q4
Increased
2.3M
+60.1%
$7M0.0%$2.99
39
2023-Q3
Increased
1.5M
+23.9%
$1.4M0.0%$0.98
31
2023-Q2
Increased
1.2M
+10.7%
$1.6M0.0%$1.34
28
2023-Q1
Decreased
1.1M
-30.9%
$1.7M0.0%$1.67
0
2022-Q4
Increased
1.5M
+43.9%
$9.6M0.0%$6.23
37
2022-Q3
Increased
1.1M
+179.4%
$7.2M0.0%$6.84
44
2022-Q2
Increased
382,403
+173.3%
$2.4M0.0%$6.67
42
2022-Q1
Decreased
139,899
-59.2%
$649,0000.0%$4.89
0
2021-Q4
New
342,647
-
$1.7M0.0%$4.96
36
2021-Q2
Exited
0
-100.0%
$00.0%$21.13
0
2021-Q1
Decreased
48,670
-6.3%
$1.4M0.0%$27.44
0
2020-Q4
Increased
51,964
+174.5%
$1.4M0.0%$28.15
41
2020-Q3
Decreased
18,930
-32.7%
$704,0000.0%$37.46
0
2020-Q2
New
28,132
-
$1.4M0.0%$47.64
35
2019-Q4
Exited
0
-100.0%
$00.0%$59.82
0
2019-Q3
Decreased
39,484
-72.7%
$1.4M0.0%$37.78
0
2019-Q2
Increased
144,774
+490.4%
$6.7M0.0%$46.52
44
2019-Q1
New
24,522
-
$985,0000.0%$40.15
35

Other major holders of ESPR: BNP PARIBAS FINANCIAL MARKETS, Pentwater Capital Management LP, WASATCH ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used